Results
1430
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1430 companies
Omega Therapeutics
Market Cap: US$1.8m
Operates as a clinical-stage biotechnology company.
OMGA.Q
US$0.033
7D
-8.3%
1Y
-98.2%
Stem Cells Spin
Market Cap: zł6.8m
Operates as a biotechnology company in Poland.
SCS
zł0.17
7D
3.0%
1Y
-63.8%
Cai Lay Veterinary Pharmaceutical
Market Cap: ₫47.5b
Manufactures and supplies veterinary pharmaceutical products in Vietnam and Indochina.
MKV
₫9,500.00
7D
0%
1Y
2.2%
1933 Industries
Market Cap: CA$2.5m
Engages in the cultivation, extraction, and production of cannabis products in the United States.
TGIF
CA$0.005
7D
0%
1Y
-66.7%
Labocanna
Market Cap: zł6.6m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.32
7D
-5.1%
1Y
-21.5%
TNF Pharmaceuticals
Market Cap: US$1.7m
A clinical-stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms.
TNFA
US$0.17
7D
-2.9%
1Y
-91.2%
Can B
Market Cap: US$1.7m
Develops, manufactures, and sells hemp biomass derived products containing cannabinoids.
CANB
US$0.021
7D
-22.0%
1Y
18.2%
Eevia Health Oyj
Market Cap: SEK 15.7m
Produces and distributes organic bioactive plant extracts in Finland and internationally.
EEVIA
SEK 0.12
7D
-9.8%
1Y
-80.6%
Medigene
Market Cap: €1.4m
A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.
MDG1
€0.088
7D
0.2%
1Y
-96.4%
Algernon Pharmaceuticals
Market Cap: CA$2.2m
Operates as a clinical stage pharmaceutical development company in Canada and Australia.
AGN
CA$0.075
7D
0%
1Y
-48.3%
Vectus Biosystems
Market Cap: AU$2.4m
Engages in the medical research and development activities in Australia.
VBS
AU$0.045
7D
-25.0%
1Y
-49.4%
West Island Brands
Market Cap: CA$2.0m
Engages in the medical marijuana business.
WIB
CA$0.13
7D
0%
1Y
4.0%
Lipigon Pharmaceuticals
Market Cap: SEK 13.8m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.097
7D
2.3%
1Y
-65.3%
TILT Holdings
Market Cap: CA$2.0m
Provides various cannabis products and services in the United States, Canada, and internationally.
TILT
CA$0.005
7D
0%
1Y
-88.9%
Aptahem
Market Cap: SEK 13.2m
A biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions.
APTA
SEK 1.10
7D
-4.3%
1Y
-64.1%
Intravenous Infusions
Market Cap: GH₵13.7m
A pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region.
IIL
GH₵0.05
7D
0%
1Y
0%
Vaxxinity
Market Cap: US$1.3m
A biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.
VAXX
US$0.0001
7D
0%
1Y
-99.9%
Decipher Labs
Market Cap: ₹105.6m
Manufactures, markets, sells, and trades in pharmaceutical drugs in India and internationally.
524752
₹10.46
7D
-12.4%
1Y
-36.6%
Beryl Drugs
Market Cap: ₹102.2m
Engages in the manufacture and marketing of various branded and generic pharmaceutical formulations in India.
524606
₹20.15
7D
9.2%
1Y
-36.5%
Cian Healthcare
Market Cap: ₹101.0m
Engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India.
542678
₹4.04
7D
5.5%
1Y
-81.1%
Captor Capital
Market Cap: CA$1.5m
Engages in the retail sale of cannabis products in the United States.
CPTR
CA$0.48
7D
7.9%
1Y
-20.0%
International Stem Cell
Market Cap: US$1.1m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.14
7D
-6.6%
1Y
59.8%
Street Capital
Market Cap: CA$1.4m
Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.
STRC.X
CA$0.005
7D
0%
1Y
0%
Adastra Holdings
Market Cap: CA$1.3m
Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.
XTRX
CA$0.24
7D
0%
1Y
-87.4%
Ovoca Bio
Market Cap: €856.4k
A clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health.
OVXA
€0.011
7D
0%
1Y
10.5%
Spermosens
Market Cap: SEK 9.0m
Provides diagnostic health care products and services in Sweden.
SPERM
SEK 0.007
7D
-12.5%
1Y
-88.7%
RAMM Pharma
Market Cap: CA$1.2m
Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.
RAMM
CA$0.01
7D
0%
1Y
-50.0%
Prostatype Genomics
Market Cap: SEK 7.7m
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests.
PROGEN
SEK 1.30
7D
11.6%
1Y
-97.8%
DanCann Pharma
Market Cap: DKK 5.2m
A biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas.
DANCAN
DKK 1.41
7D
6.8%
1Y
-96.9%
Avenue Therapeutics
Market Cap: US$787.4k
A specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases.
ATXI
US$0.26
7D
4.1%
1Y
-93.1%
Univo Pharmaceuticals
Market Cap: ₪2.8m
Univo Pharmaceuticals Ltd engages in the development, production, and supply of medical cannabis products.
UNVO
₪0.093
7D
0%
1Y
-94.3%
CBD Life Sciences
Market Cap: US$775.0k
Engages in the development and marketing a line of cannabidiol based organic products.
CBDL
US$0.0002
7D
-20.0%
1Y
-96.4%
cbdMD
Market Cap: US$696.7k
Produces and distributes various cannabidiol (CBD) products in the United States.
YCBD
US$0.98
7D
1.7%
1Y
-81.6%
TC Biopharm (Holdings)
Market Cap: US$630.9k
A clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States.
TCBP.Y
US$0.30
7D
0%
1Y
-99.8%
Altamira Therapeutics
Market Cap: US$625.3k
Operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe.
CYTO.F
US$0.092
7D
3.8%
1Y
-93.8%
Fabino Enterprises
Market Cap: ₹52.0m
A pharmaceutical company, develops, manufactures, markets, trades in, and packages pharmaceutical and other wellness focused consumer products in India.
543444
₹24.75
7D
-1.0%
1Y
-9.3%